Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Castón JJ, Cano A, Pérez-Camacho I, Aguado JM, Carratalá J, Ramasco F, Soriano A, Pintado V, Castelo-Corral L, Sousa A, Fariñas MC, Muñoz P, Abril López De Medrano V, Sanz-Peláez Ó, Los-Arcos I, Gracia-Ahufinger I, Pérez-Nadales E, Vidal E, Doblas A, Natera C, Martínez-Martínez L, Torre-Cisneros J.
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(5): 1452-1460. Nº de citas: 21
-
Fortún J.
Diagnostic and therapeutic approach to fungal pneumonia in the critically ill patient.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 35 Suppl 1: 97-103. Nº de citas: 2
-
Domínguez-Domínguez L, Rava M, Bisbal O, Lopez-Cortés L, Portilla J, Podzamczer D, Olalla J, Fuster D, Rubio R, Jarrín I, Iribarren JA, Moreno S.
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018.
BMC INFECTIOUS DISEASES . 22(1): 379-379.
-
Bouza E, Arribas JR, Alejos B, Bernardino JI, Coiras M, Coll P, Del Romero J, Fuster MJ, Górgolas M, Gutiérrez A, Gracia D, Hernando V, Martínez-Picado J, Martínez Sesmero JM, Martínez E, Moreno S, Mothe B, Navarro ML, Podzamczer D, Pulido F, Ramos JT, Ruiz-Mateos E, Suárez García I, Palomo E.
Past and future of HIV infection. A document based on expert opinion.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(2): 131-156.
-
Martínez-Sanz J, Vivancos-Gallego MJ, Fernández-Felix BM, Muriel A, Pérez-Elías P, Uranga A, Romero B, Galán JC, Moreno S, Pérez-Elías MJ.
An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.
Microbiology spectrum . 10(2): . Nº de citas: 1
-
García-Botella A, García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, Bouza E.
Booster or additional vaccination doses in patients vaccinated against COVID-19.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(2): 105-114. Nº de citas: 6
-
García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, García-Botella A, Bouza E.
Pharmacological treatment of COVID-19: an opinion paper.
REVISTA ESPANOLA DE QUIMIOTERAPIA . 35(2): 115-130. Nº de citas: 30
-
Varona JF, Landete P, Lopez-Martin JA, Estrada V, Paredes R, Guisado-Vasco P, Fernandez de Orueta L, Torralba M, Fortun J, Vates R, Barberan J, Clotet B, Ancochea J, Carnevali D, Cabello N, Porras L, Gijon P, Monereo A, Abad D, Zuñiga S, Sola I, Rodon J, Vergara-Alert J, Izquierdo-Useros N, Fudio S, Pontes MJ, de Rivas B, Giron de Velasco P, Nieto A, Gomez J, Aviles P, Lubomirov R, Belgrano A, Sopesen B, White KM, Rosales R, Yildiz S, Reuschl AK, Thorne LG, Jolly C, Towers GJ, Zuliani-Alvarez L, Bouhaddou M, Obernier K, McGovern BL, Rodriguez ML, Enjuanes L, Fernandez-Sousa JM, Krogan NJ, Jimeno JM, Garcia-Sastre A.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Life Science Alliance . 5(4): . Nº de citas: 8
-
Martínez-Sanz J, Ron R, Moreno E, Sánchez-Conde M, Muriel A, López Cortés LF, Blanco JR, Pineda JA, Mena Á, Calzado Isbert S, Moreno S, Serrano-Villar S.
Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV.
Frontiers in immunology . 13: 873408-873408. Nº de citas: 2
-
Albasanz-Puig A, Durà-Miralles X, Laporte-Amargós J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Pallarès N, Bergas A, Carratalà J, Gudiol C, On Behalf Of The Ironic Study Group.
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia.
Microorganisms . 10(4): .
-
Moreno S, Alcázar B, Dueñas C, González Del Castillo J, Olalla J, Antela A.
Use of Antivirals in SARS-CoV-2 Infection. Critical Review of the Role of Remdesivir.
DRUG DESIGN DEVELOPMENT AND THERAPY . 16: 827-841. Nº de citas: 5
-
Maza MDC, Úbeda M, Delgado P, Horndler L, Llamas MA, van Santen HM, Alarcón B, Abia D, García-Bermejo L, Serrano-Villar S, Bastolla U, Fresno M.
ACE2 Serum Levels as Predictor of Infectability and Outcome in COVID-19.
Frontiers in immunology . 13: 836516-836516. Nº de citas: 5
-
Serrano-Villar S, López-Huertas MR, Jiménez D, Galera C, Martínez-Sanz J, Moreno E, Muriel A, Gutiérrez F, Busca C, Portilla J, Bisbal O, Iribarren JA, Tejerina F, de Los Santos I, Moreno S.
Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens.
Frontiers in immunology . 13: 848630-848630. Nº de citas: 3
-
Manzano M, Talavera-Rodríguez A, Moreno E, Madrid N, Gosalbes MJ, Ron R, Dronda F, Pérez-Molina JA, Lanza VF, Díaz J, Moreno S, Navia B, Serrano-Villar S.
Relationship of Diet to Gut Microbiota and Inflammatory Biomarkers in People with HIV.
Nutrients . 14(6): . Nº de citas: 1
-
Albóniga OE, Jiménez D, Sánchez-Conde M, Vizcarra P, Ron R, Herrera S, Martínez-Sanz J, Moreno E, Moreno S, Barbas C, Serrano-Villar S.
Metabolic Snapshot of Plasma Samples Reveals New Pathways Implicated in SARS-CoV-2 Pathogenesis.
JOURNAL OF PROTEOME RESEARCH . 21(3): 623-634. Nº de citas: 1
-
Sainz T, Diaz L, Rojo D, Clemente MI, Barbas C, Gosalbes MJ, Jimenez-Hernandez N, Escosa L, Guillen S, Ramos JT, Muñoz-Fernández MÁ, Navarro ML, Mellado MJ, Serrano-Villar S.
Targeting the Gut Microbiota of Vertically HIV-Infected Children to Decrease Inflammation and Immunoactivation: A Pilot Clinical Trial
Nutrients . 14(5): . Nº de citas: 6
-
Podzamczer D, Micán R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, Ribera E, Vivancos MJ, Morano L, Masiá M, Gómez C, Fanjul F, Payeras A, Inciarte A, Estrada V, Rivero A, Castro Á, Bernal E, Vinuesa D, Knobel H, Troya J, Macías J, Montero M, Sanz J, Navarro-Alcaraz A, Caicedo A, Fernández G, Martínez E, Moreno S.
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Open forum infectious diseases . 9(3): .
-
Balandín B, Ballesteros D, Pintado V, Soriano-Cuesta C, Cid-Tovar I, Sancho-González M, Pérez-Pedrero MJ, Chicot M, Asensio-Martín MJ, Silva JA, de Luna RR, Gesso CM, Rodríguez-Serrano DA, Martínez-Sagasti F, Royuela A.
Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 59(3): 106536-106536. Nº de citas: 10